| Issue | Title | Abstract | File |
| No 3 (2022) | Changes in body mass index among students from different countries before and during the COVID-19 pandemic | Abstract |
 (Rus) |
| Mingazov R.N., Gureev S.A., Tliashinov A.O., Mingazova E.N. | |||
| No 2 (2025) | Changes in the positions of domestic manufacturers in the regional market because of offset contracts’ supplies of medicinal products | Abstract |
(Rus) |
| Trofimova E.O., Aleshechkina Y.A. | |||
| No 1-2 (2019) | Changes in VED list: an opportunity that came true | Abstract |
(Rus) |
| Prozherina J., Shirokova I. | |||
| No 7-8 (2020) | Changing breast cancer prognosis | Abstract |
(Rus) |
| Prozherina Y., Shirokova I. | |||
| No 4 (2023) | Characteristics of the structure of arriving foreign citizens in the Republic of Tatarstan | Abstract |
(Rus) |
| Minullin I.K., Vafina G.G., Bildyuk E.V., Garifullina I.V., Bychkova S.A., Eremeeva Z.G. | |||
| No 11 (2018) | Characterization of export prospect of domestic anti-influenza vaccines in Latin American countries and Carribeans | Abstract |
(Rus) |
| Trukhin V.P., Narkevich I.A., Nacharova E.P., Uiba S.V., Basakina I.I. | |||
| No 3 (2019) | Chelovek legche perenosit golod, chem poteryu sna. Interv'yu s Ol'goy Vorob'evoy | Abstract |
(Rus) |
| Article E. | |||
| No 1-3 (2020) | Chem opasna bessonnitsa i kak s ney borot'sya? | Abstract |
(Rus) |
| Article E. | |||
| No 11 (2019) | Chronic vein diseases: a pressing issue of our time | Abstract |
(Rus) |
| Beregovykh R., Prozherina Y. | |||
| No 1-2 (2019) | Classification issues of GMP-inspection deficiencies: regulatory practices | Abstract |
(Rus) |
| Orlov V.A., Shestakov V.N. | |||
| No 9 (2018) | Classification of the Republic of Sakha (Yakutia) municipal districts by level of pharmaceutical aid provided using mathematical methods | Abstract |
(Rus) |
| Tarabukina S.M., Moshkova L.V. | |||
| No 11 (2018) | Climacteric syndrome: issues in modern pharmacotherapy | Abstract |
(Rus) |
| Prozherina J., Ilyukhina E. | |||
| No 2 (2024) | Clinical and economic evaluation of the use of favipiravir in treatment regimens for COVID-19 | Abstract |
(Rus) |
| Krysanov I.S., Gurevich K.G., Matveeva N.V., Matveev A.V., Zaslavskaya K.Y., Krysanova V.S., Ermakova V.Y., Kurkin D.V., Balykova L.A., Belyi P.A., Zemskov D.N., Makarova E.V. | |||
| No 1-2 (2019) | clinical guidelines. history of creation and development in the Russian Federation and abroad | Abstract |
(Rus) |
| Kovaleva M.Y., Sukhorukikh O.A. | |||
| No 11-12 (2020) | Clinical trials in the Coronavirus era: management of risks | Abstract |
(Rus) |
| Vodovozov A. | |||
| No 4 (2024) | Clinical — economic indicators of the effectiveness of pharmacotherapy in two different therapy for psoriasis vulgaris | Abstract |
(Rus) |
| Khokhlov A.L., Samarina E.I., Lileeva E.G. | |||
| No 1-2 (2018) | Collecting of organizations' tax debts from its executives: how and when? | Abstract |
(Rus) |
| Lavrentieva A. | |||
| No 9 (2019) | Combination of private and public interests in the legal regulation of gene technologies | Abstract |
(Rus) |
| Mokhov А.А., Yavorskiy A.N. | |||
| No 3 (2023) | Communication barriers as a factor in reducing the effectiveness of campaigns on children's vaccination | Abstract |
(Rus) |
| Adamov D.A. | |||
| No 10 (2020) | Comorbid patient with non-alcoholic fatty liver disease | Abstract |
(Rus) |
| Shirokova E.N. | |||
| No 10 (2020) | Comparative analysis of business models of top pharmaceutical manufacturing companies: financial analysis | Abstract |
(Rus) |
| Yasinskaya L.E. | |||
| No 3 (2024) | Comparative analysis of standards in the field of quality management system at all stages of the life cycle of medical devices | Abstract |
(Rus) |
| Gertsik Y.G., Roschin D.O., Aksenova A.M. | |||
| No 1 (2023) | Comparative analysis of temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection | Abstract |
(Rus) |
| Motygullina L.I., Tukhbatullina R.G. | |||
| No 3 (2025) | Comparative analysis of the assortment of the drug «Insulin» in various pharmaceutical market | Abstract |
(Rus) |
| Gribkova E.I., Vinogradova P.D., Ebzeeva A.M., Merkulov A.V., Tihonov A.V. | |||
| No 9 (2020) | Comparison and analysis of the fda approved orphane drugs register and the vital and essential drugs list of the Russian Federation | Abstract |
(Rus) |
| Yurochkin D.S., Leshkevich A.A., Golant Z.M., Narkevich I.A. | |||
| No 2 (2024) | Conceptual aspects of the development of an educational program for advanced training of medical personnel in nutritional support | Abstract |
(Rus) |
| Belysheva O.A., Ananchenkova P.I. | |||
| No 7-8 (2018) | Conceptual issues of the federal state supervision reform in the sphere of circulation of drugs | Abstract |
(Rus) |
| Shevyrev D.N. | |||
| No 4 (2021) | Conflict of interest in retail sales of medicines: raising an issue | Abstract | |
| Matveev A.G., Mezentseva E.S. | |||
| No 11 (2019) | Construct validation and reliability analysis of a questionnaire to evaluate the factors influencing pharmacy staff's recommendation of over-the-counter drugs in Vietnam | Abstract |
(Rus) |
| Tran V.D., Dorofeeva V.V., Lagutkina T.P. | |||
| No 3 (2023) | Continuous training as a condition for ensuring the competence level of medical personnel | Abstract |
(Rus) |
| Smirnova E.K., Gurtskoy L.D. | |||
| No 12 (2019) | Contract manufacturing and R&D: emerging trends for the global pharmaceutical market | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 3 (2018) | Contribution of the european forum for good clinical practice to improvement of the clinical trial process in Russia and other post-soviet countries | Abstract |
(Rus) |
| Kubar O.I. | |||
| No 2 (2024) | Contribution of the Research Institute of Healthcare Organization and Medical Management to the development of Moscow healthcare (1994–2024) | Abstract |
(Rus) |
| Aksenova E.I., Kamynina N.N., Nechaev O.I. | |||
| No 4 (2023) | Corporate employee health promotion programs as an element of socially responsible policy of companies | Abstract |
(Rus) |
| Egiazarov Y.G. | |||
| No 4 (2022) | Corporate social policy of the company as a basis for the development of solutions in the field of health management: review of foreign literature | Abstract |
(Rus) |
| Zudin A.B., Vvedensky A.I., Krekova M.M. | |||
| No 1 (2025) | Cost-effectiveness of increasing the function of the medical position of a district physician-phthisiatrist | Abstract |
(Rus) |
| Bezuglaya S.Y., Posadsky M.Y., Krivtsova O.V., Tuktarova L.M., Bogorodskaya E.M. | |||
| No 11 (2018) | Cough and cold combinations market: what do Russians choose? | Abstract |
(Rus) |
| Prozherina J. | |||
| No 2 (2022) | COVID-19 burden: emotions of fear in healthcare providers | Abstract |
(Rus) |
| Goncharenko E.V., Sagitova G.R., Murzova O.A., Shaforostova E.M. | |||
| No 4-6 (2020) | COVID-19 vaccine: seeking salvage | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 2 (2021) | COVID-19: not by vaccine alone | Abstract |
(Rus) |
| Gandel V. | |||
| No 1 (2021) | CRA University - School of Clinical Trial Monitors: 10 years of success | Abstract |
(Rus) |
| Semenov-Tyan-Shanskiy V.L., Bal’Tserovich A.S., Sazonova A.N., Loginovskaya O.A., Verbitskaya E.V., Malikova E.A., Kolbin A.S., Zvartau E.E., Pavlovich D.M. | |||
| No 1-3 (2020) | Curbing the insomnia epidemic | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 2 (2023) | Current issues of medicines disposal from pharmacy organizations | Abstract |
(Rus) |
| Sharapov S.S. | |||
| No 3 (2019) | Current state and prospects of the russian market for nonwovens and kits: surgical kits, medical ware, linen | Abstract |
(Rus) |
| Vanin A. | |||
| No 13S (2018) | Cursor: analytical Review of auctions for medicinal products the territory of Russia at year-end 2017 | Abstract |
(Rus) |
| Article E. | |||
| No 7-8 (2019) | Czech pharmacies: from the social role to marketing | Abstract |
(Rus) |
| Prozherina Y. | |||
| No 13S (2018) | Defeating Cancer: R-Pharm aligns itself with the world immunonocology and cellular therapy | Abstract |
(Rus) |
| Article E. | |||
| No 1 (2021) | Defeating stroke | Abstract |
(Rus) |
| Prozherina Y.P. | |||
| No 9 (2019) | Dementia drugs market analysis in Russia | Abstract |
(Rus) |
| Trofimova Е.О., Izvekov N.V. | |||
| No 3 (2024) | Demographic processes in the conditions of innovative development of Tajikistan | Abstract |
(Rus) |
| Subhonov A.I. | |||
| No 13S (2018) | Demographic situation World market | Abstract |
(Rus) |
| Article E. | |||
| No 4 (2018) | Deshevye ZhNVLP mogut poluchit' zashchitnuyu markirovku besplatno | Abstract |
(Rus) |
| Article E. | |||
| No 1-2 (2019) | Designing clinical studies: research question | Abstract |
(Rus) |
| Melikhov O.G. | |||
| No 1 (2023) | Determination of management tactics for patients with cervical diseases based on the calculation of the prognostic index | Abstract |
(Rus) |
| Aminodova I.P., Vasilev M.D., Makarova E.V., Beneslavskaya O.A. | |||
| No 4 (2021) | Development of a pharmaceutical waste management system for medicines generated in the process of circulation among the population in the Republic of Tatarstan | Abstract | |
| Tukhbatullina R.G., Khabibulin I.R. | |||
| No 4 (2024) | Development of an organizational technology for managing risk factors for the development of habitual miscarriage | Abstract |
(Rus) |
| Plutnitsky A.N., Grishina N.K., Vartanyan E.A., Mikhailov I.A. | |||
| No 4 (2021) | Development of proposals for improving the processes of circulation of extemporal drugs and regulation of prescription and production activities of pharmaceutical organizations in the Russian Federation | Abstract | |
| Narkevich I.A., Golant Z.M., Yurochkin D.S., Leshkevich A.A., Erdni-Garyaev S.E. | |||
| No 3 (2022) | Development of rapid analysis of eye drops for monitoring during various technological operations | Abstract |
(Rus) |
| Ivanova V.E., Zhilyakova E.T., Sazonova V.E. | |||
| No 9 (2019) | Development of the rare (orphan) drug market | Abstract |
(Rus) |
| Yurochkin D.S., Golant Z.M., Narkevich I.A. | |||
| No 4-6 (2020) | Diabet pod kontrolem dazhe vo vremya epidemii | Abstract |
(Rus) |
| Shirokova I. | |||
| No 5 (2019) | Diabetic polyneuropathy: from problem to solution | Abstract |
(Rus) |
| Prozherina J. | |||
| No 2 (2021) | Diabeticheskaya polineyropatiya – ot profilaktiki k patogeneticheski obosnovannomu lecheniyu | Abstract |
(Rus) |
| - -. | |||
| No 1-2 (2018) | Digital biomedicine and biopharmaceutics | Abstract |
(Rus) |
| Koshechkin K.A., Yavorsky A.N. | |||
| No 2 (2025) | Digital competencies of a medical professional: a modern standard of professionalism | Abstract |
(Rus) |
| Baranova T.V., Gurtskoy L.D., Smirnova E.K., Andrusov V.E., Burkovskaya Y.V. | |||
| No 2 (2023) | Digital competencies of medical professionals: self-assessment of formation | Abstract |
(Rus) |
| Gurtskoy L.D., Smirnova E.K., Zudin A.B. | |||
| No 10 (2018) | Digital systems to generate an electronic dossier and support the procedure for registration of medicinal products | Abstract |
(Rus) |
| Koshechkin K.A., Rychikhina E.M., Olefir Y.V. | |||
| No 3 (2025) | Digital technologies and telemedicine in the glaucoma screening and prevention system | Abstract |
(Rus) |
| Luginin P.L., Oynotkinova O.S. | |||
| No 4 (2024) | Digital transformation as a means of ensuring GxP compliance | Abstract |
(Rus) |
| Koshechkin K.A., Spichak I.V. | |||
| No 3 (2022) | Digital transformation of pharmaceutical companies in the conditions of import substitution | Abstract |
(Rus) |
| Koshechkin K.A., Ignatiev A.A., Lebedev G.S., Fartushny E.N. | |||
| No 13S (2018) | Digitalization in the healthcare and the pharmaceutical industry quo vadis? | Abstract |
(Rus) |
| Lavrentieva A. | |||
| No 1-2 (2019) | Digital-strategii v farmbiznese: tochki rosta | Abstract |
(Rus) |
| Shirokova I. | |||
| No 9 (2018) | Dina Khasanova: «Samoe vazhnoe v uspeshnom lechenii insul'ta - svoevremennaya gospitalizatsiya bol'nogo v spetsializirovannoe meditsinskoe uchrezhdenie» | Abstract |
(Rus) |
| Article E. | |||
| No 1 (2021) | Distributors-2020 | Abstract |
(Rus) |
| Nechaeva Y. | |||
| No 9 (2018) | Does the future lie with infusion hepatoprotection? | Abstract |
(Rus) |
| Prozherina J., Shirokova I. | |||
| No 11-12 (2020) | Dolya rossiyskoy medtekhniki v goszakupkakh sostavit 50-60% v 2021 godu | Abstract |
(Rus) |
| Article E. | |||
| No 1-2 (2018) | Dopolnitel'nye polnomochiya dlya Roszdravnadzora | Abstract |
(Rus) |
| Article E. | |||
| No 2 (2021) | Dostupnost' vs innovatsii: v poiskakh balansa | Abstract |
(Rus) |
| Kuminova E. | |||
| No 4 (2024) | Drug insurance: modern products on the market in Russia and their development prospects | Abstract |
(Rus) |
| Kondrashov A.A., Kurashov M.M., Loskutova E.E. | |||
| No 6 (2018) | Drug labelling: experience of implementation and prospects | Abstract |
(Rus) |
| Slinyakov Е.Е. | |||
| No 1-3 (2020) | Drug product release in 2019 | Abstract |
(Rus) |
| Romanova S. | |||
| No 1 (2021) | Dvizhenie - tsel': kak izmenitsya lechenie SMA v etom godu v Rossii | Abstract |
(Rus) |
| Kuminova E. | |||
| No 3 (2025) | E. M. Dementiev — sanitary doctor and public figure (175th anniversary of his birth) | Abstract |
(Rus) |
| Egorysheva I.V., Chalova V.V. | |||
| No 11 (2019) | EAEU registration procedure: opportunities for work automation | Abstract |
(Rus) |
| Olefir Y.V., Rychikhina E.M., Koshechkin K.A. | |||
| No 4 (2021) | Economic overview of the Russian pharmaceutical market during the pandemic crisis | Abstract | |
| Bazhenova S.A., Grammova E.A. | |||
| No 11 (2019) | Efficacy of original bacterial lysate in COPD affected by comorbidity: pharmacoeconomic aspect | Abstract |
(Rus) |
| Chelenkova I.N., Olefir Y.V., Krylov I.A., Bunyatyan N.D. | |||
| No 7-8 (2019) | Eksport kak tochka rosta otechestvennoy farmindustrii | Abstract |
(Rus) |
| Shirokova I. | |||
| No 9 (2020) | Elena Artamonova: «Primenenie ingibitorov CDK4/6 v kombinatsiis gormonoterapiey pozvolilo dvukratno uvelichit' prodolzhitel'nost' zhizni patsientok s HR+/HER2-mRMZh» | Abstract |
(Rus) |
| Article E. | |||
| No 1-2 (2018) | Elena Kolyutskaya: «Ispol'zovanie sovremennykh antipsikhotikov sushchestvenno izmenilo klinicheskiy prognoz shizofrenii» | Abstract |
(Rus) |
| Article E. | |||
| No 1 (2025) | Epidemiological characteristics of sexually transmitted infections in combination with HIV infection in the Republic of Tatarstan | Abstract |
(Rus) |
| Eremeeva Z.G., Vafina G.G., Bildyuk E.V., Minullin I.K. | |||
| No 4 (2022) | Ethical aspects of corporate health promotion programs of medical university employees (by the example of COVID-19 prevention) | Abstract |
(Rus) |
| Zorin K.V., Toporkov V.A., Gurevich K.G., Pustovalov D.A. | |||
| No 4 (2022) | Evaluation of publication activity and analysis of the topic clusters in the subject area «health policy» | Abstract |
(Rus) |
| Aksenova E.I., Ananchenkova P.I., Tarkhov K.Y. | |||
| No 3 (2022) | Evaluation of the effectiveness of the state policy aimed at increasing the attractiveness of rural areas for the settlement of young dentists | Abstract |
(Rus) |
| Stepanova Y.S., Kopytov A.A. | |||
| No 10 (2019) | Evgeniy Shlyakhto: «Sovmestnaya rabota nad innovatsionnymi proektami - zalog uspeshnoy realizatsii zadach, stoyashchikh pered rossiyskim zdravookhraneniem» | Abstract |
(Rus) |
| Article E. | |||
| No 13S (2018) | Evolution from import substitution to expansion into the foreign markets | Abstract |
(Rus) |
| Article E. | |||
| No 3 (2022) | Evolution of medical informatics in the system of medical knowledges: historical aspect | Abstract |
(Rus) |
| Lukmanov A.H. | |||
| No 7-8 (2019) | Exclusive rights protection practice in the pharmaceutical sector and trends of its development | Abstract |
(Rus) |
| Borzova M. | |||
| No 2 (2023) | Experience in providing urological care during the COVID-19 pandemic | Abstract |
(Rus) |
| Sarkisyan A.D., Shapovalenko T.V., Darenkov S.P., Agamov Z.H. | |||
| No 3 (2023) | Experience in reorganizing the emergency medical and emergency services of the Moscow region | Abstract |
(Rus) |
| Kustov E.V., Suslonova N.V., Garanina I.A. | |||
| No 11-12 (2020) | Experience of using surfactant therapy for pneumonia associated withCOVID-19 of obstetric patients | Abstract |
(Rus) |
| Shvechkova M.V., Kukarskaya I.I., Marchenko R.N., Achmatgaraev V.V., Kukarskaya E.A., Shvechkova A.S. | |||
| No 3 (2025) | Experience of using VR technologies in training specialists in the field of pharmacy | Abstract |
(Rus) |
| Glukhova A.A., Krasheninnikov A.E., Rozhnova S.A. | |||
| 101 - 200 of 814 Items | << < 1 2 3 4 5 6 7 8 9 > >> | ||
REMEDIUM
ISSN 1561-5936 (Print) ISSN 2658-3534 (Online) |
User
×
User